Community Healthcare CEO gets 26,853 restricted shares

Community Healthcare Trust Inc (CHCT) reported that CEO and President David H. Dupuy acquired 26,853 shares of common stock as a compensation-related grant.

Rhea-AI Filing Summary

Community Healthcare Trust Inc (CHCT) reported that CEO and President David H. Dupuy acquired 26,853 shares of common stock as a compensation-related grant. The shares are restricted stock with a three-year restriction period, and were valued using an average share price of $15.46. Following this grant, Dupuy directly holds 584,115 common shares.

Dupuy agreed to receive 50% of his 2026 cash bonus in restricted stock, and the company awarded him additional restricted stock equal to 15% of his cash bonus, both based on the same 10‑day average share price.

Insider Trade Summary

Grant/Award: 26,853 shares

Grant/Award 1 txn

Insider Dupuy David H.

Role CEO and President

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	26,853	$15.46	$415K

Holdings After Transaction: Common Stock — 584,115 shares (Direct)

Footnotes (1)

1. F1. For 2026, the reporting person agreed to take 50% of his cash bonus in shares of restricted stock with a three-year restriction period. Because the reporting person elected to take 50% of his bonus for 2026 in shares of restricted stock with a three-year restriction period, the Company awarded Mr. Dupuy additional compensation, in restricted stock, equal to 15% of his cash bonus. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding August 18, 2026, which was $15.46.

Key Figures

Shares acquired: 26,853 shares Price per share for grant valuation: $15.46 Shares owned after transaction: 584,115 shares +2 more

5 metrics

Shares acquired 26,853 shares Restricted stock grant to CEO David H. Dupuy on 2026-08-18

Price per share for grant valuation $15.46 Average price over 10 trading days immediately preceding August 18, 2026

Shares owned after transaction 584,115 shares Direct common stock holdings of David H. Dupuy following grant

Cash bonus taken in stock 50% Portion of 2026 cash bonus that Dupuy agreed to take in restricted stock

Additional restricted stock compensation 15% of cash bonus Extra restricted stock awarded equal to 15% of Dupuy’s 2026 cash bonus

Key Terms

restricted stock, three-year restriction period, cash bonus, average price, +1 more

5 terms

restricted stock financial

"take 50% of his cash bonus in shares of restricted stock with a three-year restriction period"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

three-year restriction period financial

"shares of restricted stock with a three-year restriction period"

cash bonus financial

"take 50% of his cash bonus in shares of restricted stock"

average price financial

"based on the average price of the Company's common stock for the 10 trading days"

10 trading days financial

"for the 10 trading days immediately preceding August 18, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did CHCT CEO David H. Dupuy report on this Form 4?

David H. Dupuy reported acquiring 26,853 shares of Community Healthcare Trust common stock as restricted stock. These shares were granted as part of his 2026 bonus compensation, with a three-year restriction period on the stock.

How many CHCT shares does David H. Dupuy hold after this reported transaction?

After the reported grant, David H. Dupuy directly holds 584,115 shares of Community Healthcare Trust common stock. This figure reflects his position following the 26,853-share restricted stock award disclosed in the Form 4 filing.

What was the price used to value the restricted stock granted to CHCT CEO David H. Dupuy?

The restricted stock was valued using an average price of $15.46 per share. This price equals the average trading price of Community Healthcare Trust’s common stock over the 10 trading days immediately preceding August 18, 2026.

How is David H. Dupuy’s 2026 bonus from CHCT structured in this Form 4 disclosure?

Dupuy agreed to take 50% of his 2026 cash bonus in restricted stock with a three‑year restriction. In addition, Community Healthcare Trust awarded extra restricted stock equal to 15% of his cash bonus as additional compensation.

Is the CHCT Form 4 transaction a market purchase or a compensation award?

The transaction is a compensation-related grant, not an open-market purchase. The Form 4 describes it as restricted stock issued for Dupuy’s 2026 bonus, with the value based on a 10‑day average share price of $15.46.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 04:16 PM Accepted by SEC EDGAR 08/18/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dupuy David H.

(Last) (First) (Middle)

3326 ASPEN GROVE DR

SUITE 150

(Street)

FRANKLIN TENNESSEE 37067

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Community Healthcare Trust Inc [ CHCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/18/2026		A		26,853(1)	A	$15.46	584,115	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. For 2026, the reporting person agreed to take 50% of his cash bonus in shares of restricted stock with a three-year restriction period. Because the reporting person elected to take 50% of his bonus for 2026 in shares of restricted stock with a three-year restriction period, the Company awarded Mr. Dupuy additional compensation, in restricted stock, equal to 15% of his cash bonus. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding August 18, 2026, which was $15.46.

Remarks:

	/s/ Nathanael P. Kibler, Attorney-in-fact	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)